Medtech’s top executive moves in 2024

The new year ushered in a wave of changes in executive suites across the medtech landscape. Several medical device and diagnostics companies have named new CFOs, while others have found new leaders. Among the comings and goings: Agilent promoted Padraig McDonnell to succeed retiring CEO Mike McMullen, and QuidelOrtho fired its CEO, Doug Bryant, after nearly 15 years at the helm.

Medtronic added a chief sustainability officer, a new role for the company.

Illumina appointed a new CFO and a chief strategy and corporate development officer, as the genomics specialist pivots to unwind its $8 billion Grail acquisition under CEO Jacob Thaysen.

Here’s a collection of MedTech Dive’s coverage of executive moves in the industry so far this year. MedTech Dive will update this roundup throughout the year:

How Pfizer ended up passing on my GLP-1 work back in the early ’90s

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class of drugs. But the

September 9, 2024

New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy

A machine learning-based heart disease prediction model (ML-HDPM) that uses various combinations of information and numerous recognized categorization methods.

April 5, 2024

Most states have yet to permanently fund 988. Call centers want certainty.

Since the National Suicide Prevention Lifeline transitioned a year ago to the three-digit crisis phone number 988, there has been a 33% increase in the

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.